A new remedy may help to relieve chronic hepatitis
The developers have reported on the successful completion of Myrcludex B interim tests. Myrcludex B is a drug intended to patients with chronic hepatitis B (delta agent). As "Remedium" notes, the drug has been tested on 120 patients for 24 weeks. During that time the volunteers had no serious side effects. This proves the safety of the therapy.
Medicine for multiple sclerosis will fight against resistant bacteria
Glatiramer acetate is a medicinal product, used to treat multiple sclerosis for 20 years. It turns out that it is able to cope with antibiotic resistant bacteria. As Zee News notes, experts say that the drug is safe and has no serious side effects.
Discovery: genes determine the life expectancy of cancer patients
A new study, carried out by scientists from the United States, involved 365 people suffering from pancreatic adenocarcinoma. The tumor could be removed surgically. The researchers have found that the life expectancy of patients depends on changes in the four genes, The Indian Express reports.
Breakthrough: Genetics have partially restored vision to blind people
A group of scientists has created a new gene therapy designed to help patients who lost their vision due to a hereditary disease - Leber congenital amberosis. The therapy can restore vision to the point where a person can navigate in a maze in dim light, The Deccan Chronicle reports.
The use of statins after a heart attack may save your life
As The Daily Mail notes, the risk of another heart attack, stroke and premature death is reduced by approximately 25% in people taking statins (cholesterol-lowering drugs) after a stroke or heart attack. A new study carried out by scientists from the United States has made such conclusions.
A unique implant is able to improve memory
A brand new brain implant has been designed by experts from the University of Southern California. It stimulates the brain region associated with learning ability and memory. Thanks to the implant, experiment participants began to cope with the task for memory much better, The Daily Mail reports.
Researchers learned more about HIV
As The Deccan Chronicle notes, scientists from the University of Chicago have found out how HIV spreads throughout the body. Probably, the discovery of the scientists may lead to the development of new drugs for HIV infection. According to the scientists, when the cell infected, HIV makes the cell to form a small capsule with the virus from its membrane.
ANANTA MEDICARE took part in the international pharmaceutical exhibition CPhI Worldwide in Frankfurt, Germany
The largest annual international pharmaceutical exhibition CPhI Worldwide took place in Frankfurt am Main, Germany on October 24-26, 2017. More than 45,000 pharmacy visitors have visited CPhI Worldwide and other events, such as ICSE, InnoPack, P-MEC and FDF. More than 2,500 companies from 153 countries took part in the exhibition and more than 150 industry seminars were held.
A new drug is able to protect cancer patients from nerve damage
According to rough estimates, 30% to 40% of cancer patients undergoing chemotherapy, experience neurologic disorder such as peripheral neuropathy. It is characterized by tingling, numbness, weakness and pain in the hands and feet as usual. A new drug can prevent cancer patients from this disorder, Zee News reports.
Stroke-preventing drugs reduce the risk of dementia
People with atrial fibrillation who take anticoagulants (drugs preventing the blood clots formation) rarely experience the dementia. This conclusion was made by scientists of the Karolinsky Institute. The scientists have analyzed the data of 444106 people from Sweden for 2006-2014. Participants had atrial fibrillation, which increases the risk of stroke.